- $294.16bn
- $307.74bn
- $196.91bn
- 88
- 73
- 60
- 86
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 140,156 | 94,471 | 155,606 | 235,717 | 196,913 |
Cost of Revenue | |||||
Gross Profit | 60,060 | 43,983 | 66,234 | 90,301 | 77,717 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 137,063 | 99,875 | 138,224 | 193,817 | 171,779 |
Operating Profit | 3,093 | -5,404 | 17,382 | 41,900 | 25,134 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5,536 | -7,453 | 21,639 | 49,674 | 29,584 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,848 | -5,561 | 15,689 | 35,608 | 21,411 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,924 | -5,543 | 15,625 | 35,465 | 21,369 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,924 | -5,543 | 15,625 | 35,465 | 21,369 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.27 | -1.25 | 8.22 | 18.5 | 12.7 |
Dividends per Share |